Which of the following are benefits of tenecteplase over previous generations of thrombolytics?
•
2 min read
Recent clinical trials have increasingly demonstrated that tenecteplase (TNK) is a highly effective alternative to older thrombolytics, with a 2024 meta-analysis showing superior outcomes for early neurological recovery in acute ischemic stroke patients. These studies highlight key advantages answering the question: **Which of the following are benefits of tenecteplase over previous generations of thrombolytics?**
